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Abstract: The porcine cytomegalovirus (PCMV) is a herpesvirus that may pose a risk for
xenotransplantation using pig cells, tissues, or organs. Here, three orthotopic pig heart transplantations
into baboons were studied. To detect PCMV, a real-time PCR and a Western blot assay based on
four PCMV protein sequences, including two tegument proteins, were used. The transmission of
PCMV from the donor pig to the recipient baboon was found in two cases, despite PCMV not being
detected in the blood of the donor pigs by real-time PCR. Although it was not in the blood, PCMV was
detected in different organs of the donor pigs, and in sibling animals. Immunohistochemistry using
an antiserum that is specific for PCMV detected virus protein-expressing cells in all of the organs of
the recipient baboon, most likely representing disseminated pig cells. Therefore, for the first time,
the distribution of PCMV in organs of the donor pigs and the recipient baboons was described.
In addition, baboon cytomegalovirus (BaCMV) was found activated in the recipient, and a screening
for hepatitis E virus (HEV) and porcine lymphotropic herpesviruses (PLHV) was performed. For the
first time, a cross-reactivity between antibodies directed against PCMV and BaCMV was found.
Keywords: porcine cytomegalovirus; virus transmission; xenotransplantation; virus safety
1. Introduction
Xenotransplantation is at present the most promising solution for overcoming the increasing
shortage of human organs for the treatment of organ failure [1]. This shortage is the reason why
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a large number of individuals die on the waiting list for the required organ [2]. Pigs are for several
reasons the most suitable donor species. These reasons include the size of the organs, the functional
compatibility (for example, pig insulin has been used successfully for the treatment of diabetes over
decades), and the ability to create cloned and genetically modified pigs in a short time [3,4]. However,
the transplantation of pig cells, tissues, and organs may not only save and prolong human life, it may
also be associated with the transmission of potentially zoonotic porcine microorganisms, and the
porcine cytomegalovirus (PCMV) among them [5,6]. PCMV is widely distributed among pigs; it is
a rather stable DNA virus that can easily be transmitted from pig to pig by milk, urine, and faeces [7,8].
Transplacental transmission of PCMV has also been described [8,9]. When evaluating the risk posed
by PCMV, it was found that the survival time of pig kidneys from PCMV-infected pigs transplanted
into baboons [10] or cynomolgus monkeys [11] was significantly reduced, indicating that PCMV may
also pose a risk for clinical xenotransplantation [12–14]. The transmission of PCMV was also observed
after pig heart transplantation, which was associated with injury of the transplant, and an increased
incidence of consumptive coagulopathy [15]. Early weaning excluded PCMV, resulted in a prolonged
survival of the transplant, and prevented consumptive coagulopathy [15].
To detect PCMV in pigs, sensitive PCR-based methods [16–20] have been developed, as well
as immunological methods screening for PCMV-specific antibodies as an indirect marker of virus
infections [21–23]. Screening pigs for PCMV demonstrated that sensitive PCR-based methods have to
be used, since less sensitive methods gave false-negative results [18]. To eliminate PCMV from pig
herds, elimination programs based on treatment, early weaning, colostrum deprivation, Caesarean
delivery, and embryo transfer have been proposed (for a review, see [24]).
Recently, we reported on the transmission of PCMV after transplantation of a pig heart into
a baboon, even though PCMV was not detected in the blood of the donor pig [25]. Here, this and
two other cases of orthotopic pig heart transplantations were analysed in detail, and for the first time,
an analysis of the prevalence and tissue distribution of PCMV in donor pigs and the recipient baboons
is reported.
2. Materials and Methods
2.1. Animals and Transplantations
All of the donor pigs (3701, 5154, 5292) and their siblings (5157, 5160 to 5154) were
triple genetically modified; all were crossbreeds of German Landrace and Large White,
with an alpha1,3-galactosyltransferase gene-knockout (GalT-KO), expressing human CD46 and human
thrombomodulin (hTM) (Revivicor, Blacksburg, VA, USA, and Institute for Molecular Animal Breeding
and Biotechnology, Faculty of Veterinary Medicine, LMU, Munich, Germany). GalT-KO pigs do
not express the Gal epitope, which is the major cell surface determinant toward natural occurring
antibodies that induce the so-called hyperacute rejection (HAR). Animal 5014 was a male Landrace pig
with GalT-KO and expressing hTM, animal 5016 was a male Landrace pig with GalT-KO, and animal
5017 was a male Landrace pig with GalT-KO expressing CD46, all born 4 May 2016.
The first transplant recipient, a four-year-old male baboon (#57), was transplanted and treated as
described [25]. The transplantation and treatment of baboons 64 (male, four years old) and baboon 62
(male, four years old) was performed similarly.
For the establishment of a new testing strategy, peripheral blood monoculear cells (PBMCs) from
pigs 89030, 91106, 91107, 91111, 91112, 91117, 01118, 91119, and 91122 were used. These pigs were
DanAvl basic hybrid sows; they are not genetically modified, and they were derived from a specified
pathogen-free (SPF) facility in Fehmarn, Germany. In December 2016, at an age of approximately
11 months, they had been tested positive for hepatitis E virus (HEV) using PCR, and negative for
porcine lymphotropic herpesviruses (PLHV)-1, -2, -3 and porcine circovirus 2 (PCV2) using PCR.
The baboons were obtained from the German Primate Center, Göttingen, Germany. Housing
of the baboons was in accordance with national regulations (see Ethic statement). Enrichment for
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primates was individually adapted to each animal. In addition, a “clicker training” was performed.
Blood samples were taken from the pigs and baboons after the induction of anesthesia before the
transplantation. Second blood samples, as well as tissue samples, were taken after euthanisation of
the baboons.
Premedication of the pigs consisted of intramuscular injections of ketamine hydrochloride
10–20 mg/kg (Ketavet® 100 mg/mL, Pfizer Deutschland GmbH, Berlin, Germany), azaperone 10 mg/kg
(Stresnil® 40 mg/mL, Lilly Deutschland GmbH, Bad Homburg, Germany), and atropine sulfate
(Atropinsulfat B. Braun 0.5 mg, B. Braun Melsungen AG, Melsungen, Germany). General anesthesia was
induced with an intravenous bolus of 20 mg propofol (Propofol®-Lipuro 2%, B. Braun Melsungen
AG, Melsungen, Germany) and 0.05 mg fentanyl (Fentanyl-Janssen 0.5 mg, Janssen-Cilag GmbH,
Neuss, Germany). Anesthesia was maintained with the continuous infusion of propofol 7 mg/kg/h;
analgesia was achieved by intravenous bolus injections of 2.5 µg/kg fentanyl repeated every 30 min if
necessary. Donor pigs were euthanised by applying cardioplegia and subsequently explanting the heart
in deep anesthesia.
Premedication of the baboons consisted of an intramuscular injection of ketamine hydrochloride
10 mg/kg and 0.5 mg/kg midazolam (Midazolam-ratiopharm, ratiopharm GmbH, Ulm, Germany).
General anesthesia was induced with an intravenous bolus of 1.5–2.5 mg/kg propofol and 0.05 mg
fentanyl. Anesthesia was maintained with the continuous infusion of 5–15 mg/kg propofol,
and analgesia was achieved by intravenous bolus injections of 6–8 µg/kg fentanyl repeated
every 45 min. A continuous infusion of fentanyl, ketamine hydrochloride, and metamizole
(Novaminsulfon-ratiopharm® 1 g/2 mL, ratiopharm GmbH, Ulm, Germany) was applied after
transplantation to ensure analgesia. Baboons were euthanised by explanting the pig heart in
deep anesthesia.
Orthotopic pig-to-baboon cardiac xenotransplantations were carried out according to the
technique of Lower and Shumway [26]. Telemetric transmitters were implanted during surgery,
which allowed for continuous post-surgical cardiovascular monitoring (blood pressure and
electrocardiography). During the early postoperative period, a fixed regime of fentanyl, ketamine
hydrochloride, and metamizole was administered. Analgesic treatment was then adjusted and
stopped depending on clinical inspection (activity, posture, feed intake, contacting) and hemodynamic
parameters (blood pressure, heart rate) as indirect signs of pain and distress. If necessary, analgesic
treatment was restarted during the experiment.
Score sheets were used to describe the animals’ distress. Humane endpoints were defined
by various conditions resistant to treatment such as automutilation, anorexia, vomitus, diarrhoea,
impaired wound healing, bleeding, and pleural effusions. The experiment was terminated if one or
more of these conditions were observed, or if a predefined maximum score was exceeded.
All animals were euthanised when humane endpoints were reached. No mortality occurred
outside of planned euthanasia or humane endpoints.
2.2. Ethics Statement
Both the generation of transgenic animals, as well as interventions on re-cloned animals, were
performed with permission of the local regulatory authority, Regierung von Oberbayern (ROB),
Sachgebiet 54, 80534 München (approval numbers, AZ 55.2-1-54-2532-70-12, 20 November 2012 and
AZ 55.2-1-54-2532-163-14). Applications were reviewed by the ethics committee according to §15 TSchG
German Animal Welfare Law. The xenotransplantation experiment was approved by the Government
of Upper Bavaria, Munich, Germany (reference number 55.2-1-54-2532-184-2014, September 2015).
Housing, feeding, environmental enrichment, and steps taken to minimise suffering, including the use
of anesthesia and method of sacrifice, was in accordance with the recommendations of the Weatherall
report “The use of non-human primates in research”.
Viruses 2018, 10, 66 4 of 20
2.3. Testing for PCMV, HEV and BaCMV, PCR Methods
PCMV testing was performed as described [17,21,27,28] using specific primers (Table 1). Briefly,
DNA was extracted from sera and blood of the pigs using two DNA extraction kits, a DNeasy Blood
and Tissue kit (Qiagen GmbH, Hilden, Germany) and a ZR viral DNA kit (Zymo Research Corp., Irvine,
CA, USA). DNA was quantified using a NanoDrop ND-1000 (Thermo Fisher Scientific Inc., Worcester,
MA, USA). DNA was isolated from organs using the DNeasy Blood & Tissue Kit. To screen for PCMV,
a real-time PCR with a detection limit of two to five copies was performed using a SensiFast probe no
ROX one-step kit, according to supplier recommendations (Bioline GmbH, Germany). Then, 60 ng of
DNA were used for testing. The reaction mixture contained 400 nM of both primers, and 100 nM of
the probe (Table 1) in a final volume of 20 µL. The following conditions for amplification were used:
denaturation at 95 ◦C for 5 min, and 45 cycles of amplification with denaturation at 95 ◦C for 10 s,
annealing at 59 ◦C for 20 s, and extension at 60 ◦C for 25 s. Reporter fluorescence was measured using
an Mx3005P Multiplex Quantitative PCR System (Stratagene, La Jolla, CA, USA).
To test for HEV, RNA was isolated and a real-time PCR was performed as described [29,30] using
specific primers (Table 1).
To test for baboon cytomegalovirus (BaCMV), a real-time PCR was performed as described [31]
using specific primers (Table 1).
Viruses 2018, 10, 66 5 of 20
Table 1. Primers and probes used for real-time PCR. BaCMV: baboon cytomegalovirus; PLHV: porcine lymphotropic herpesviruses; PCMV: porcine cytomegalovirus
Primers Used for PCR Sequence 5′-3′ Nucleotide Position Accession Number Reference
PLHV-1,-2 (747) fw
PLHV-1,-2 (747) rev
CAYGGTAGTATTTATTCAGACA
GATATCCTGGTACATTGGAAAG
21,146–21,167
21,488–21,467 AY170317.1 Ehlers B., 2002 [32]
PLHV-3 (905) fw
PLHV-3 (905) rev
ACAAGAGCCTTAGGGTTCCAAACT
GTGTCCAGTGTTGTAATGGATGCC
13,472–13,495
13,727–13,704 AY170316.1 Chmielewicz et al., 2003 [33]
Primers and probes used for real-time PCR
pcyclophilin real fw
pcyclophilin real rev
pcyclophilin probe
TGCTTTCACAGAATAATTCCAGGATTTA
GACTTGCCACCAGTGCCATTA
Cy5-TGCCAGGGTGGTGACTTCACACGCC-BHQ
131–158
187–207
161–185
AY008846 Duvigneau et al., 2005 [34]
pGAPDH fw
pGAPDH rev
pGAPDH probe
ACATGGCCTCCAAGGAGTAAGA
GATCGAGTTGGGGCTGTGACT
HEX-CCACCAACCCCAGCAAGAG-BHQ1
1040–1062
1188–1168
1114–1132
NM_001206359.1 Duvigneau et al., 2005 [34]
JVHEVF
JVHEVR
JVHEVProbe
GGTGGTTTCTGGGGTGAC
TGATTCTCAGCCCTTCGC
FAM-TGATTCTCAGCCCTTCGC-BHQ
5283–5300
5352–5335
5306–5323
KT633715.1 Jothikumar et al., 2006 [35]
PCMV real fw
PCMV real rev
PCMV probe
ACGAGAAAGATATTCTGACGGTGCA
TCTAGACGAAAGGACATTGTTGATA
6FAM-CAGGGCGGCGGTCGAGCTC-TAMRA
45,962–45,938
45,622–45,646
45,246–45,229
KF017583.1 Mueller et al., 2004 [36]
BaCMV real fw
BaCMV real rev
BaCMV probe
5′ GTTTAGGGAACCGCCATTCTG 3′
5′ GTATCCGCGTTCCAATGCA 3′
5′ 6FAM-TCCAGCCTCCATAGCCGGGAAGG-BBQ 3′
64,375–64,396
64,464–64,483
64,437–64,460
KR351281 Mueller et al., 2002 [31]
BaCCR5 real fw
BaCCR5 real rev
BaCCR5 probe
5′ TACCTGCTCAACCTGGCCAT 3′
5′ TTCCAAAGTCCACTGGGC 3′
HEX-TTTCCTTCTTACTGTCCCCTTCTGGGCTC-BHQ 3′
Mueller et al., 2002 [31]
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2.4. Determination of the PCMV Copy Number
To determine the copy number of PCMV, a standard plasmid covering the target DNA of the
PCMV PCR was generated. For this, the amplificate was cloned into a TOPO vector using the Zero
Blunt TOPO PCR kit (Invitrogen Corporation, Carlsbad, CA, USA). The generated plasmid was diluted
from 2× 105 to 0.1 copies per reaction to obtain a standard curve by real-time PCR. DNA from different
organs, and the blood before and post mortem of baboon 64 and the donor pig, were analysed.
2.5. Determination of the BaCMV Copy Number
A droplet digital PCR was established to measure the BaCMV copy numbers using the
QX200™Droplet Digital™PCR System (Bio-Rad Laboratories Inc., Hercules, CA, USA). PCR reactions
were carried out as duplex PCR using baboon CCR5 as a housekeeping gene. Primer and probes were
adopted from Mueller et al. [31]. PCR reaction mixes were prepared as follows: 10 µL of 2*ddPCR™
Supermix for Probes (No dUTP, Bio-Rad Laboratories Inc.), 180 pmol of each primer, and 50 pmol
probe were mixed with 2 ng template DNA, isolated as described above. To complete the 20-µL
reaction volume, the appropriate amount of nuclease and protease free water was added. BaCMV
copy numbers were calculated using QuantaSoft (Bio-Rad, version 1.7.4.0917).
2.6. PBMC Incubation
Porcine PBMC were isolated by Ficoll gradient centrifugation (lymphocyte separation medium,
PromoCell, Heidelberg, Germany), using Falcon tubes without porous barriers. The isolated PBMCs
were washed with culture medium (RPMI1640, antibiotics, glutamine) and 10% foetal calf serum (FCS)
(Merck Millipore, Darmstadt, Germany). DNA was isolated before and after incubation. In some
experiments, PBMCs were incubated with mitogen phytohemagglutinin (PHA) (10 µg/mL, Millipore).
2.7. PCMV and HEV Antigens Used for Western Blot Analyses
In Western blot analyses for the detection of antibodies against PCMV, two His-tagged
recombinant parts of the glycoprotein gB of PCMV, designated R1 (N-terminal part) and R2
(C-terminal part), were cloned, produced, purified, and used as described [21]. In addition, two newly
produced tegument proteins of PCMV (U54A and U54B) [37] were cloned, produced, and purified as
described [23]. Briefly, the U54A sequence was located from 70,307-72,304 (protein ID, AGT99246.1,
GenBank No. KF017583), and the sequence of U54B was located from 72,345–73,541 (protein ID,
AGT99247.1, GenBank No. KF017583). The sequences were codon optimised using Jcat, a novel
tool to adapt codon usage [38] for bacterial expression, and synthesised by ATG biosynthetics
(Merzhausen, Germany). The sequences were cloned into the expression vector pet16b with NdeI
and XhoI restriction sites (Novagen, Madison, WI, USA). The cloned sequences were confirmed by
DNA sequencing. Both of the sequences were expressed as recombinant His-tagged fusion proteins
in E. coli BL21cells (New England Biolabs, Frankfurt/Main, Germany). The constructs were grown
in 2 L 2YT-Medium at 37 ◦C until an optical density (OD) of 0.7, followed by induction with 1 M
isopropyl β-D-1-thiogalactopyranoside (IPTG). After 3 h of induction, cells were pelleted by 8000 rpm
for 15 min, and stored at −20 ◦C until purification. Cell pellets were resuspended in buffer (PBS,
1 mg/mL lysozyme, Sigma-Aldrich, St. Louis, MO, USA, and 50 µL benzonase, Merck Millipore,
Darmstadt, Germany), sonicated three times for 20 s, and incubated on ice for 20 min. The cell
debris was removed by centrifugation (11,000 rpm, 10 min), and pellets were extracted with lysis
buffer (6 M guanidinium chloride, 500 mM NaCl, 20 mM disodium phosphate pH 7.5) overnight at
room temperature. Solubilised proteins were separated from the remaining insoluble material by
centrifugation (2 × 11,000 rpm, 15 min), diluted to 100 mL lysis buffer, and loaded on HisTrap 5-mL
excel columns (GE Healthcare, Buckinghamshire, UK). The columns were equilibrated with lysis buffer,
and loaded with solubilised proteins. After washing with lysis buffer and a second wash buffer (8 M
urea, 500 mM NaCl, 30 mM (UA) or 20 mM (UB) imidazole, 20 mM disodium phosphate pH 7.5),
Viruses 2018, 10, 66 7 of 20
the proteins were eluted using a 10-column volume gradient with elution buffer (8 M urea, 500 mM
NaCl, 500 mM imidazole, 20 mM disodium phosphate pH 7.5).
In order to detect antibodies against HEV, the GT3 antigen was used [29,30].
2.8. Testing for PCMV, HEV and PLHV
Western blot analysis was performed using 500 ng/lane of the corresponding antigen. The proteins
were dissolved in sample buffer (50 mM Tris-HCl, 12% glycerol, 4% SDS, 5% β-mercaptoethanol,
0.01% bromophenol blue), and denaturated for 5 min at 95 ◦C prior to electrophoresis. The proteins
were analysed using 10% or 14% polyacrylamide gel and the PageRuler prestained protein ladder
(ThermoFisher, Waltham, MA, USA). Proteins were transferred for 50 min to nitrocellulose membranes
by electroblotting (15 V), stained with Ponceau red, cut into strips, and blocked overnight at 4 ◦C with
5% blotting grade dry milk (Roth) in PBS with 0.05% Tween 20 (blocking buffer). Strips were incubated
with sera diluted 1:300 in blocking buffer for 2 h at room temperature. Polyclonal goat anti-pig
immunoglobulin G (IgG)–alkaline phosphatase (AP) (Abcam, Cambridge, UK) was diluted 1:1000 in
blocking buffer. For the detection of the gB protein, a 1:1000 dilution of the Penta-His antibody (Qiagen,
Hilden, Germany) as the primary antibody, and 1:1000 polyclonal rabbit anti-mouse IgG–horseradish
peroxidase (HRP) or IgG–AP (Dako, Hamburg, Germany) were used as well. Staining was performed
with 3,3′-diaminobenzidine (DAB) (Thermo Fisher) or with 5-bromo-4-chloro-3- indolyl-phosphate
nitro blue tetrazolium (NBT/BCI) (Promega, Madison, WI, USA). Testing for PLHV-1, -2, and -3,
using PCR assays and Western blot analyses, were performed as described [39].
2.9. Immunohistochemistry (IHC)
A PCMV-specific rabbit polyclonal antibody was used in this study, which was produced by
immunising a rabbit with PCMV J1, which was the first field isolate in Japan. Immunohistochemistry
(IHC) was performed as described previously [40] using the universal immune-enzyme polymer
method with a Histofine Simple Stain MAX-PO Kit (Nichirei, Tokyo, Japan). The serial sections were
pretreated with 0.1% actinase for 20 min at 37 ◦C, and endogenous peroxidase activity was blocked
using 3% H2O2 in methanol for 30 min at room temperature. The obtained antibody was applied as
the primary antibody at a dilution of 1:1024 for 30 min at room temperature. The sections were lightly
counterstained with hematoxylin, and assessed using light microscopy. Simultaneously, sections of
porcine kidney that were known to be infected with PCMV were immunolabelled as positive controls.
Negative controls were prepared by replacing the primary antibody with a commercial Tris-HCl buffer
(antibody diluent with background reducing components) (Dako, Tokyo, Japan).
2.10. Sequence Alignment
In order to confirm the immunological cross-reactivity between PCMV and BaCMV at the
sequence level, an alignment of the sequences of the glycoproteins of both viruses was performed
using BioEdit version 7.2.5, pairwise alignment (Ibis Biosciences, Carlsbad, CA, USA) [41].
3. Results
3.1. Time Schedule of the Transplantation Experiments and Testing for PCMV
Three orthotopic pig heart transplantations into baboons were performed (Figure 1). The donor
pigs (pig 3701, pig 5154, and pig 5292) were all genetically modified, as described in the materials and
methods section. The first transplantation experiment has been partially described [25,30]; the two
others were performed similarly with slight modifications. In addition, two sibling pigs to donor pig
5154, pig 5157, and pig 5160 were also analysed.
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3.2. Detection of PCMV in Donor Pig and Baboon Recipients
All three donor pigs (3701, 5154, and 5292) were found negative when the blood of these animals
was analysed by PCR for PCMV infection. Although PCMV was not detected by real-time PCR in the
blood of donor pig 3701, the virus was transmitted to the recipient baboon 57 and a high virus titre in the
recipient suggested replication in the transplant and/or recipient [25]. Whereas the testing of animal
3701 had been performed 21 days before transplantation (Figure 1), in the second transplantation
experiment, the blood from donor pig 5154 was tested directly on the day of transplantation (day 0).
In parallel, animal 5154 and two sibling animals tested positive for hepatitis E virus (HEV) and negative
for porcine lymphotropic herpesviruses (PLHV-1, PLHV-2, PLHV-3) (Table 2). However, when animal
5160 and sibling 5157 were tested several weeks after the transplantation of the heart from donor
animal 5154, blood from both of the pigs was found positive for PCMV. To note, the blood of animal
5154 was negative for PCMV on the day of transplantation (day 0). The fact that PCMV was detected in
the blood of sibling animals 5160 and 5157 on day 30 and day 144 suggests that PCMV was replicating.
It is likely that the whole litter had been infected by the mother, since early weaning was not performed.
However, the virus did not induce antibodies against the glycoprotein (gB) of PCMV, as shown by
Western blot results, using the N-terminal part R1 and the C-terminal part R2 of gB as antigen (Table 2).
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Table 2. Screening of animals 5154 (donor pig), 5160, and 5157 (sibling pigs) for potentially zoonotic porcine viruses. HEV: hepatitis E virus; PLHV: porcine
lymphotropic herpesviruses.
Pig Number Born Gender Material Collected(Date)
PCMV
(Real-Time PCR)
HEV
(Real-Time RT PCR)
PLHV1/2
(PCR)
PLHV3
(PCR)
PCMV
(Western Blot) *
PLHV
(Western Blot) **
HEV
(Western Blot) ***
5154 1 July 2016 male 7 September 2016 no ct no ct no ct no ct negative negative negative
5160 1 July 2016 female 7 September 2016 no ct no ct no ct no ct negative negative negative
5160 3 February 2017 no ct no ct no ct no ct negative negative negative
5157 1 July 2016 female 26 October 2016 no ct no ct no ct no ct negative negative negative
* Using two antigens, R1 and R2, ** using one antigen, GB1, *** using one antigen, GT3, no ct–no threshold cycle value.
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The recipient of the heart from pig 5154, baboon 64, was found PCMV-positive 40 days after
transplantation (see below). In the third transplantation experiment (Figure 1), blood from donor pig
5292 was also found PCMV-negative on the day of transplantation. In this case, the recipient baboon
62 deceased four days later, and it was found PCMV-negative, certainly due to the short survival time
of the transplant.
Although the donor pigs were HEV-positive as shown by real-time PCR, baboons 57 and 64 were
HEV-negative [30,42].
3.3. Distribution of PCMV in Pig Organs
When the blood of donor pig 5154 was tested, it was found negative for PCMV on the day of
transplantation (day 0, Figure 1). To identify the reservoir of PCMV leading to the infection of baboon
64, different organs of this animal were screened using a real-time PCR. PCMV was found mainly in
the kidney, but also in the pancreas, liver, and spleen of animal 5154; in other organs of this animal
(lymph node, lung, and aorta), the virus was under the detection limit of the method (Figure 2).
When in parallel, the organs from three related and also genetically modified pigs—5014, 5016 and
5017—were tested for PCMV by real-time PCR (Figure 2), in these animals, the virus was found in
all of the organs analysed. The highest virus load was found in the nose (pigs 5016, 5017), the spleen
(pig 5014), and lower amounts were found in the heart (pig 5017) and kidney (pig 5016) (Figure 2).
These data indicate that (i) the copy number differed considerably from animal to animal (compare the
virus load in the nose of pig 5016 with that in the nose of pig 5017); and (ii), with exception of the nose,
in each animal, another organ showed the highest copy number (Figure 2). These differences were not
based on different ages or different litters, since animals 5014, 5016, and 5017 were born on the same
day from the same mother.
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In addition, tissue samples from pigs 5014 and pig 5016 were analysed by immunohistochemistry
(IHC), using antibodies specific for PCMV. No PCMV was detected using this method in the liver,
spleen, kidney, heart, lung, and lymph node of both animals [43]. When tissue samples from the
nose (nasal mucosa and conchen) of animal 5016 were investigated, no PCMV could be detected
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likewise. The difference in the PCR results showing the presence of the virus in some organs (Figure 2)
is certainly due to the lower sensitivity of the IHC method, or due to some cells containing viral DNA,
but not expressing the protein.
3.4. Development of a New Detection Strategy Using Incubated PBMC
Since pig 5154 was PCMV-positive in a few organs, but negative when the blood was tested
using the same real-time PCR, an analysis was performed as to whether testing for PCMV in the
blood can be improved by incubating the isolated PBMCs from the animal under study for five to
seven days in culture medium. Freshly isolated PBMCs from nine pigs were incubated and tested
before and after incubation (Figure 3). These animals were DanAvl basic hybrid sows; they were
not genetically modified, and they had been derived from a SPF facility in Fehmarn, Germany.
Twenty-eight days before this experiment, blood samples from these animals tested negative for
PCMV using PCR. After cultivation of the pig PBMCs, a significant increase in the amount of detected
virus was observed in two of nine cases (pigs 91106, 91111), and a moderate increase was observed
in three of nine cases. In four cases, no virus was detected; presumably, these animals were truly
negative, at least in the blood samples and using our detection method. Stimulating the PBMCs
with the mitogen PHA did not increase the virus replication. These data indicate that PCMV was
replicating during cultivation, and that this approach increases the efficacy of virus screening in the
blood, which may be a great advantage when testing pigs. This is a very important finding. Without
incubation, all nine animals would have been declared PCMV-negative, but using this assay, five
animals were found PCMV-positive.
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3.5. Distribution of PCMV in Baboon Organs
Whereas in the case of baboon 57, no tissues with the exception of blood and serum were available
to test for PCMV by PCR, in the case of baboons 62 and 64, different organs were available, and were
tested using real-time PCR (Figure 4). In the case of baboon 64, high numbers of viral DNA were
found in the spleen, and lower numbers of PCMV DNA copies were found in the blood and liver,
whereas only very few copies were found in the kidney. Whereas the baboon blood was negative
before transplantation, the blood after transplantation showed a detectable virus load (Figure 4).
Material from the transplanted pig heart was not available for PCR testing, but was available for IHC
studies (see below). In the case of baboon 62, all of the organs were negative [42], possibly due to the
short survival time of the recipient.
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In order to confirm the PCR results and obtain additional information about the distribution
of PCMV in the baboon, an IHC analysis was performed using PCMV-specific rabbit antibodies
(Figure 5A).
In the case of baboon 57 (where unfortunately no organs were available to screen for PCMV
by PCR), positive cells were found by IHC in the pig donor heart, as well as in all of the analysed
organs of the baboon (liver, sple n, kidney, lung, lymph n de, and testis) at th end of the experiment.
The highes amount of positive cells was found in the baboon lymph node and testis, whi a lower
amount was found in the pig heart, and lower am unts were als found in the b boon liver, spleen,
kidney, and lung. A semiquantitative presentation of the distribution in different organs as detected
by IHC is given in Table 3. The same analysis was performed with tissues from baboon 64 (Figure 6,
Table 3). A high number of PCMV-positive cells was detected in the lymph node and the spleen,
correlating with the PCR result (Figure 4), as well as in the pig donor heart; a lower number was found
in the liver, kidney, lung, and testis (Figure 6, Table 3).
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Figure 5. Immunohistochemical analysis of PCMV distribution in the pig donor heart, in different
organs from baboon 57 (A) and from control baboon 43 (B). To detect PCMV, a specific rabbit serum
was used, A, baboon 57, a,b—pig heart, c—baboon liver, d—baboon lung, e— aboon spleen, f—baboon
lymph node, g—baboon testis, h baboon kidney; B, control baboon 43, a—heart, b—kidney, c—liver,
d—lung, e—spleen. Scale bar = 50 µm.
Table 3. Results of the immunohistochemistry (IHC) analysis of different organs from two baboons
after pig heart transplantation and one control baboon.
Organ Baboons
57 64 Control 43
Liver + + + *
Spleen + ++ + *
Kidney + + + *
Pig heart ++ ++ + *
Lung + + + *
Testis +++ + n.t.
Lymph node +++ +++ n.t.
+ a few, ++ some, +++ many; * very weak reaction, cross-reactivity with BaCMV, n.t., not tested.
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3.6. Detection of the Baboon Cytomegalovirus (BaCMV) in the Recipient Baboons
Surprisingly, when a control baboon (number 43) was analysed by IHC using the rabbit serum
against PCMV, a slightly positive reaction was observed in some cells in different organs (Figure 5B,
Table 3). Since this animal had no contact to pigs and an infection with PCMV thus can be excluded,
several baboons were screened for BaCMV using a BaCMV-specific PCR method. This PCR does not
detect PCMV. BaCMV DNA was found in all of the baboons tested so far; t e distribution of BaCMV in
the different organs of baboon 64 is shown in Figure 7. This anim l was in p rallel infected by PCMV,
as shown by a PCMV-specific PCR (Figure 4). In contrast to the high load of BaCMV in the blood and
different organs of baboon 64 at day 40 after transplantation, only a very low virus load was detected
in the blood of baboon 64 before transplantation (Figure 7). The high virus load of BaCMV in the blood
of animal 64 after the transplantation (Figure 7) indicated replication (activation) of the virus during
the 40 days of transplantation, which was possibly influenced by the immunosuppressive regimen, or
by ischemia reperfusion injury concomitant with release of cytokines, chemokines, and other factors.
When control baboon 43 was tested by PCR for BaCMV, no virus was detected in the blood or serum,
which was certainly ue to the low virus load under the detection limit of our method. No other organs
were available for PCR testing. BaCMV was also detected in the blood of baboon 57 at the end of the
transplantation [42], suggesting that also in this case, the virus load increased during transplantation.
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4. Discussion
Here, for the first time, the distribution of PC V in the organs of genetically modified donor
pigs used for orthotopic heart xenotransplantation and in organs of the transplanted baboons are
described. It is important to note that PC V was found in several organs of the donor pig but not
in the blood when tested at an earlier time point, indicating that testing blood is not an efficient
way to detect PCMV in young pigs. Based on this result, the testing of organs from sibling animals of
the same litter is recommended. In addition, in a recent study, which was not yet finished when we
analysed the pigs in these transplantation experiments, we observed that testing non-invasive oral
and anal swabs by PCR may be more efficient for PC V detection compared with testing blood [44].
However, incorrect sampling of the swabs may give wrong results. Therefore, in order to increase
the efficacy of PC V detection, pig PB Cs were cultivated and tested after five days. This strategy
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significantly increased the efficacy or testing, and did not have the uncertainties of swab collection.
When the organs of the pigs were tested, the highest amount of PCMV was detected in the nose,
followed by the kidney and spleen (Figure 2). These results correlate with previous publications: in one
of these investigations, 38 PCMV genome copies/µg of DNA were found in the kidney, and 97 genome
copies/µg of DNA were found in the lung [16]. The viral load in the liver, gut, and salivary gland were
below the threshold of quantification. In general, the primary site of virus replication in pigs is believed
to be in the nasal mucous glands, the lachrymal glands, or the Harderian glands. These organs were
not available for testing in our study. The destruction of the cells in these organs results in marked
rhinitis and conjunctivitis (this explains why PCMV infection had been previously designated inclusion
body rhinitis). Widespread damage caused by the virus or secondary infections can lead to death [45].
It was shown that the replication of the latent PCMV can be significantly enhanced in transplanted
organs [31] and in culture through allogenic stimulation [46].
As mentioned above, our results showing an increase in virus load after the in vitro cultivation of
isolated pig PBMCs from infected animals (Figure 3) propose a more efficient testing for PCMV when
only the blood of the animals is available. These results are in line with the re-activation of PCMV
through allogenic stimulation, as has been shown earlier [46]. Although in our approach allogenic cells
were not added, the cultivation alone or in vitro responses to proteins present in the foetal calf serum
(FCS) of the culture medium may have activated PCMV. Although this method may significantly
increase the sensitivity of PCMV detection, since it needs at least five days for cultivation, it is not
suited for quick testing.
The detection of PCMV in cells in all of the organs of baboon recipients 57 and 64, as shown by IHC,
is one of the most impressive results of this study. Although it is still unclear whether PCMV is able to
infect baboon or human cells, most data indicate that herpes viruses are species-specific [47]. This was
also shown, for example, for mouse cytomegalovirus (CMV) [48]. In the case of PCMV and human cells,
one publication reported the infection of human fibroblasts [49], while another reported the failure
of infection of human cells, showing that the co-cultivation of PCMV-infected pig macrophages with
two human cell lines (293 and Raji) did not facilitate virus transmission [13]. Therefore, the question
of whether PCMV can infect human cells and replicate in humans is still unanswered. Our data here
suggest that porcine cells expressing PCMV antigens are found disseminated in the organism of the
recipient baboon. Inclusion bodies, a characteristic of infection, were not detected in the positive
cells; however, inclusion bodies were also occasionally not observed in previous investigations of
infected animals [40]. Quantifying the amount of positive cells in different organs of baboon 57 using
IHC analysis showed a very high amount of positive cells in the baboon lymph node and testis,
a lower amount in the pig heart, and a low amount in the other tested baboon organs (liver, spleen,
kidney, and lung) (Table 3). Similar results were obtained by IHC analysis for baboon 64. Interestingly,
in baboon 64, an extremely high amount of PCMV DNA was detected in the spleen using real-time
PCR. It remains unclear whether the difference in the findings obtained by PCR and IHC was due to
the presence of viral DNA not expressing protein, or whether different parts of the organ with different
expression profiles were used for PCR or IHC. Nevertheless, the highest amount of PCMV DNA was
found in the spleen, while lower amounts were found in the blood and liver, and nearly no PCMV was
found in the kidney (Figure 4).
Baboons are naturally infected with a cytomegalovirus, BaCMV, which has been isolated and
described by several laboratories [50]. Most of the animals tested in baboon colonies are infected and
have antibodies to BaCMV [51]. The immunological cross-reactivity between sera against PCMV and
BaCMV is of interest, especially as PCMV is more closely related to HHV-6 and HHV-7 in comparison
with HHV-5/HCMV. IHC analyses demonstrated that a rabbit serum against PCMV cross-reacts with
BaCMV-infected cells in a baboon (Figure 5B), and a Western blot analysis showed that the serum
from baboon 64 reacts with PCMV proteins before the pig heart transplantation and infection with
PCMV. Recently, it has been reported that BaCMV was transmitted after a baboon-to-human liver
xenotransplantion [52]. Replication-competent BaCMV was isolated from serial blood samples of the
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human recipient of the baboon liver on days 29, 36, and 42 after xenotransplantation. This was the first
report of detecting a replication-competent virus from a source animal after xenotransplantation into
a human, and was a concern with regard to potential zoonotic transmission to others [52]. Although
it is still unclear whether PCMV infects human cells (see above), BaCMV replicates well in human
cells in culture [53]. Human fibroblasts were permissive for BaCMV, isolates exhibited cytopathology
similar to that of HCMV, and virions were observed by electron microscopy [53].
Although the severe shortage of human organs for transplantation is the driving force behind
xenotransplantation research, non-human primates, particularly baboons, are for several reasons not
potential sources of organs and tissues. One of these reasons is that BaCMV is endemic in baboon
populations and infects human cells, and is therefore a potential cause of donor-associated disease
after xenotransplantation. In addition, it is well known that the human cytomegalovirus (HCMV) is
the most common donor-associated infection, and poses a major risk for allotransplantation. Therefore,
all efforts should be undertaken to prevent the transmission of PCMV during xenotransplantation
using cells, tissues, or organs from pigs.
Supplementary Materials: The following are available online at www.mdpi.com/1999-4915/10/2/66/s1. Figure
S1: Western blot analyses using four antigens from PCMV and sera from baboon 64. M, marker, R1, recombinant
fragment R1 of gB of PCMV, R2, recombinant fragment R2 of gB of PCMV, UA, tegument protein U54A,
UB, tegument protein U54B, A, serum from baboon 64 before transplantation, B, serum from baboon 64 after
transplantation, C, anti-His antibodies detecting the His tagged proteins, unfortunately UA was cleaved during
production and purification, 1:1000, anti-mouse antibodies 1:1000. Figure S2: Alignment of the R1 and R2 regions
of gB PCMV and BaCMV.
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